583
Views
10
CrossRef citations to date
0
Altmetric
Review Articles

A comprehensive review of treatment options for recalcitrant nongenital cutaneous warts

ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 23-40 | Received 05 Nov 2019, Accepted 24 Feb 2020, Published online: 11 Mar 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Shady Mahmoud Attia Ibrahim, Mona Soliman, Sahar Khalaf Allah Mohamed & Mohamed Mohsen Soliman. (2021) Pulsed dye laser versus Nd:YAG laser in the treatment of recalcitrant plantar warts: an intraindividual comparative study. Journal of Cosmetic and Laser Therapy 23:5-6, pages 130-136.
Read now

Articles from other publishers (9)

Sonja Radakovic, Lucie Harpain, Silic Katarina & Adrian Tanew. (2023) Complete resolution of recalcitrant disseminated cutaneous warts after partial irradiation with photodynamic therapy via presumed stimulation of a systemic immune response: A retrospective analysis of 18 cases. Journal of the European Academy of Dermatology and Venereology.
Crossref
XiaoLi Chen, Yan Xu, Li Hu & AiJun Chen. (2023) Clinical observation and study of local hyperthermia for treating plantar warts: A pilot study with 38 patients. Frontiers in Medicine 10.
Crossref
Suthinee Rutnin, Amornrut Namasondhi, Cherrin Pomsoong, Chaninan Kositkuljorn, Tanaporn Anuntrangsee & Kunlawat Thadanipon. (2023) Intralesional Measles, Mumps, Rubella Vaccine versus Tuberculin Purified Protein Derivative Injections in the Treatment of Palmoplantar and Periungual Warts: A Double-Blind Randomized Controlled Trial. Dermatology 239:1, pages 109-115.
Crossref
O. Dereure. (2022) Quoi de neuf en thérapeutique dermatologique ?. Annales de Dermatologie et de Vénéréologie - FMC 2:8, pages 2/8S101-2/8S109.
Crossref
Amany Awad, Ahmed Fawzi Ismael, Manar Sallam & Soheir Abdelgaber. (2022) Intralesional purified protein derivative versus zinc sulfate 2% in the treatment of pediatric warts: Clinical and dermoscopic evaluation. Journal of Cosmetic Dermatology 21:10, pages 4637-4645.
Crossref
L. Pagan, C. Yfanti, R. Rijneveld, M. Todd, P. Jongste, J.J. Feijen, E.S. Klaassen, J.N. Bouwes Bavinck, L. Struijk, M.N.C. de Koning, L. Prestegarden, T. Niemeyer‐van der Kolk, M.I.E. van Poelgeest & R. Rissmann. (2022) Results of a randomized, placebo‐controlled, first‐in‐human trial of topical CY ‐002 in patients with cutaneous warts . Journal of the European Academy of Dermatology and Venereology 36:10.
Crossref
Leila Youssefian, Amir Hossein Saeidian, Ali Reza Tavasoli, Elnaz Kalamati, Karim Naghipoor, Amir Hozhabrpour, Mehrnaz Mesdaghi, Zahra Saffarian, Hamidreza Mahmoudi, Mohammad Nabavi, Sima Shokri, Sirous Zeinali, Vivien Béziat, Jean-Laurent Casanova, Emmanuelle Jouanguy, Jouni Uitto & Hassan Vahidnezhad. (2022) Recalcitrant Cutaneous Warts in a Family with Inherited ICOS Deficiency. Journal of Investigative Dermatology 142:9, pages 2435-2445.
Crossref
Tsu-Man Chiu, Ping-Chun Hsu, Mohd Yaqub Khan, Cheng-An J. Lin, Chun-Hung Lee, Tsai-Ching Hsu, Min-Hua Chen & Nobutaka Hanagata. (2021) A Perspective on Imiquimod Microneedles for Treating Warts. Pharmaceutics 13:5, pages 607.
Crossref
Marcelo Grossi Araújo, Geraldo Magela Magalhães, Lucas Campos Garcia, Érica Cristina Vieira, Maria de Lourdes Ribeiro de Carvalho-Leite & Antônio Carlos Martins Guedes. (2021) Update on human papillomavirus – Part II: complementary diagnosis, treatment and prophylaxis. Anais Brasileiros de Dermatologia 96:2, pages 125-138.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.